“[The secretary] determined that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad and that involves Zika virus,” a Food and Drug Administration statement reads.
The CDC plans to distribute the test to qualified laboratories both in the U.S. and in other countries over a two week period. The antibody testing window is from about four days after infection to 12 weeks, according to the CDC. Testing outside of this window can return a false-negative. No commercially available FDA-approved tests currently exist.
More articles on Zika:
CDC investigates 14 new sexually transmitted Zika cases in US
Zika & Guillian- Barré Syndrome linked? Investigation of 2013 outbreak produces strong evidence
Chicago’s first Zika virus case confirmed
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
